Bevacizumab (mAb-based) ELISA Assay Kit, Eagle Biosciences, Inc.

Supplier: Eagle Biosciences

IG-AB104
103389-224EA 2040 USD
103389-224
Bevacizumab (mAb-based) ELISA Assay Kit, Eagle Biosciences, Inc.
Assays ELISAs

Bevacizumab mAb-based ELISA precisely measures free Bevacizumab in serum and plasma samples.


  • Dynamic Range: 6 - 200 ng/mL
  • Sensitivity: 2 ng/mL
  • Incubation: 2 hours


The drug Bevacizumab (trade name Avastin® ) is a recombinant human IgG1::k monoclonal antibody specific for all human vascular endothelial growth factor-A (VEGF-A) isoforms and it has been approved by the FDA as a first-line treatment for metastatic colorectal cancer in combination with chemotherapy. Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration. The specificity of this testsystem is achieved by using a monoclonal antibody named "MAY-2B5" for the coating of the microtiter plate. This antibody is specific for Bevacizumab only and does not cross react with other VEGF catchers.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR